|Articles|July 15, 2006
Prophylactic, therapeutic use of mitomycin-C considered safe
Literature review shows single application of low-dose MMC can prevent, treat haze after surface procedures
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approvals in 2025: What changed and why it matters for ophthalmologists
2
PRIMAvera study: Central vision improvement with subretinal implant
3
Achieving a new level of refractive precision: Surgical strategies
4
Q&A: What changed in residency education in 2025? Perspectives from training directors
5